The model of investing huge amounts of money into one drug to try to recoup it later is problematic at best and unsustainable at worst. Platform technology provides a better, more cost-effective way forward.
To stay competitive and differentiate themselves, hospitals, physicians and practices must use technology to enhance the patient experience while simultaneously improving outcomes.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Healthcare, like much of the rest of the economy, is facing a labor shortage. Artificial intelligence can lighten the load for overworked providers through everything from automation to triaging patients.
Called the Innovator Community Expansion Initiative, the main goal of the effort is to pinpoint and remove obstacles keeping underrepresented groups, like women, out of the innovation process. The initiative will promote networking and education about the path to commercialization.
Tendo Systems, a company that is co-developing a digital engagement platform with provider organizations like Jefferson Health, raised $50 million in a new funding round. The funds will be used to advance the development of the platform, which aims to be the "OpenTable" of healthcare.
In a wide-ranging interview, Dr. Geoff Vince, the new executive director of Cleveland Clinic Innovations, discussed his plans for how the commercialization arm will operate, the technologies he thinks will drive interest and whether the pandemic has changed approaches to innovation.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Covid-19 pandemic has upended the healthcare industry in a myriad of ways — including the focus of IT innovation. Healthcare CIOs are seeing IT innovation priorities shift to arenas like at-home care, data science and supply chain.
During a panel discussion at the J.P. Morgan Healthcare Conference, three physicians from Stanford Medicine discussed the investment opportunities that can help accelerate innovation in healthcare in the coming year.
As precision medicine gains steam, the question arises: how can reimbursement models evolve to support these often costly therapies and ensure patient access is not blocked? Drugmakers and payers are working together to find some answers.
The Florida-based hospital plans to launch the fund next year, under the leadership of a newly named vice president of innovation. It will be used to support startups and invest directly in healthcare companies.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
While payers and policymakers took a more narrow-minded perspective on innovation value in 2020, the year 2021 will bring an increased focus on a treatment’s societal value, how innovation interacts with digital technologies, and whether new innovations are able to reduce existing health outcome inequalities.
The drug industry maintains that policies like foreign reference pricing and letting Medicare negotiate prices would harm innovation. But closer examination reveals that while there is truth to that claim, it's more complex than it appears at first glance.
The second edition of the Manova Summit in Minneapolis October 14-16 will take a wider perspective of healthcare transformation.
Unlike other industries, where artificial intelligence has successfully replaced many human interactions, healthcare must remain human first, technology second.
The two organizations have teamed up to establish an innovation lab, which will apply technology and analytics to Sanofi's real-world database in an effort to better understand diseases and which treatments work for patients.